Trial also will test pausing immunosuppressive medication to improve antibody response. The National Institutes of…
Browsing: National Institute of Allergy and Infectious Diseases
The National Institute of Allergy and Infectious Diseases (NIAID) is a part of the U.S. National Institutes of Health (NIH) and is primarily responsible for conducting and supporting research to study the causes, treatments, and prevention of infectious and immune-mediated diseases. Established in 1955, NIAID plays a crucial role in responding to emerging public health threats such as the HIV/AIDS epidemic, influenza, tuberculosis, malaria, and more recently, the COVID-19 pandemic. The institute supports a broad range of research from basic science investigating the pathogenesis of disease to clinical trials and vaccine development. NIAID also provides funding to a network of research institutions worldwide. Directed by Dr. Anthony Fauci since 1984, NIAID has been instrumental in promoting better health outcomes and advancements in understanding immune system function and management of infectious diseases. The research conducted and supported by NIAID is pivotal in developing strategies to control and prevent diseases that threaten millions of lives globally.
A single infusion of the CIS43LS antibody prevented malaria in humans for up to nine…
Large-Scale Clinical Trial Validates AstraZeneca Vaccine Results from a large clinical trial in the United…
COVID-19 variants may spread more easily and resist some antibodies, but current vaccines still protect…
New Trial Tests Monoclonal Antibody Combo for COVID-19 A Phase 2/3 clinical trial has begun…
The combination of baricitinib, an anti-inflammatory drug, and remdesivir, an antiviral, reduced the time to…
The National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of…
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of…
A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen…
A fourth Phase 3 clinical trial evaluating an investigational vaccine for coronavirus disease 2019 (COVID-19)…
A Phase 3 clinical trial designed to evaluate if an investigational vaccine can prevent symptomatic…
NIAID-sponsored phase 1 trial tested mRNA vaccine An investigational vaccine, mRNA-1273, designed to protect against…
More than 300 scientists and clinicians from the federal government, industry, and academia published a…
Study is a wake-up call for the potential of another such outbreak, as vaccination rates…
The investigational antiviral remdesivir is superior to the standard of care for the treatment of…
Study provided data for clinical testing to commence. A single dose of ChAdOx1 nCoV-19, an…
Study enrolling adults with mild to moderate COVID-19 in the United States. A clinical trial…
Coronaviruses are a large family of viruses that usually cause mild to moderate upper-respiratory tract…